Amerise Biosciences Q1 FY27 Results: Net Loss of ₹0.1 Cr
Amerise Biosciences Ltd reported a net loss of ₹0.1 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.1 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Amerise Biosciences Ltd reported a net loss of ₹0.1 Cr for Q1 FY27.
Amerise Biosciences Ltd reported revenue from operations of ₹0.1 Cr (-50.0% YoY) and net profit of ₹0.1 Cr (+0.0% YoY) for Q4 FY26.
Amerise Biosciences Ltd reported audited standalone financial results for the year ended March 31, 2026, with total income of ₹0.26 Crore and a net profit of ₹0.016 Crore. The board approved these results in a meeting concluded on May 5, 2026. The auditor issued an unmodified opinion on the performance.